Submitted by Administrator on Wed, 11/07/2018 - 14:46
AMR, which includes bacterial resistance to existing antibiotics, is on the rise and poses a significant threat to health across the world. Without a better understanding of how to tackle and prevent AMR, treatable infections could become life-threatening and the advancements made in modern medicine over recent decades are at risk of being reversed.
The competition follows the announcement of £30 million to fund research and development projects as part of the Global AMR Innovation Fund (GAMRIF) in May 2018 with CARB-X, the Foundation for Innovative New Diagnostics (FIND), the Argentinian government, and Canada’s International Development Research Centre (IDRC).
The £10 million will be made available in research grants funded through a Small Business Research Initiative (SBRI). It is being run by Innovate UK on behalf of the Department of Health and Social Care, with the aim of supporting the implementation of the UK Five Year Antimicrobial Resistance Strategy.
Today’s competition, which makes available a maximum of £10 million in funding to successful bids, forms part of funding announced in October 2017 at the global ‘Call to Action’ conference by the Wellcome Trust, the UN Foundation, and the UK, Ghanaian and Thai governments, to accelerate action in this area.
To read the full press release, please visit the GOV.UK news site.